close
Add to watchlist
World Heart Corp (WHRT) Healthcare, Medical Equipment & Supplies
World Heart Corporation, together with its subsidiaries, primarily focuses on the manufacture, development, commercialization, and distribution of implantable ventricular assist devices (VADs). The VADs are mechanical assist devices that supplement the circulatory function of the heart by re-routing blood flow through a mechanical pump allowing for the restoration of normal blood circulation for treatment of patients with severe heart failure. The company primarily focuses on the development of Levacor Rotary VAD, a rotary blood pump for a range of circulatory support indications; Pediatric VAD, a magnetically levitated, axial rotary VAD for use in newborns and infants; and Minimally Invasive VAD, a miniature maglev rotary pump that provides partial circulatory support in patients at an earlier stage of heart failure. World Heart Corporation sells its products in the United States, Europe, Canada, and Japan. It has a strategic alliance with Abiomed, Inc. The company was founded in 1996 and is headquartered in Oakland, California.
(login to add this stock to your watchlist or favorites)
Key Statistics
| Closing Price | 0.29 |
| Volume | 130742 |
| Volume Avg | 9919 |
| 52 Week High | 1.29 |
| 52 Week Low | 0.17 |
| PE | N/A |
| PE (group average) | 39 |
| EPS Year | -0.35 |
| EPS change Q/Q | -1000% |
| EPS change Q/Q Yr ago | -1000% |
| EPS change Q/Q next Q est | -100% |
| EPS change Y/Y | -260.87% |
| REV change Q/Q | 1000% |
| REV change Q/Q Yr ago | 1000% |
| EPS next Q est | 0.00 |
| EPS next Y est | 0.00 |
| Divident Annual | 0.00 |
| Dividend Yield | 0% |